BioCatalystWatch
IRWDWorkspace / IRWD / OverviewCompany library
IRONWOOD PHARMACEUTICALS INC logo

IRONWOOD PHARMACEUTICALS INC

IRONWOOD PHARMACEUTICALS INC (IRWD)

Website

Featured programme · apraglutide

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

apraglutide

Peptide

PreINDP1P2P3FilingApproved
Upcoming / outlook

Partner / License out

Peptide

GC-C

PreINDP1P2P3FilingApproved

Approved / commercial

Peptide

GC-C

Approved

PreINDP1P2P3FilingApproved

Peptide

GC-C

Approved

PreINDP1P2P3FilingApproved

History / paused

apraglutide

Peptide

PreINDP1P2P3FilingApproved

Disease-specific pathogenic antigens (unspecified)

PreINDP1P2P3FilingApproved

GC-C

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

IRWD PR & News

PR & News

IRWD SEC archive